Fig. 7
Expression of CALD1 in ovarian serous cystadenocarcinoma based on individual cancer stages. Stage 1 exhibited the smallest sample size, limited to one case, potentially indicating that early detection of ovarian cancer is more challenging. The expression level of CALD1 at stage3 and stage 4 was significantly increased compared with stage2 (P < 0.05), while stage 4 had no statistical significance compared with stage 3. This result suggests CALD1 is associated with the disease stage. ( * indicates P < 0.05, ** indicates P < 0.01)